Research Article

Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program

Table 2

Main indicators of the pilot PCa screening program in Pavlodar region, 2013–2017.

No.IndicatorYearTotal for 5 years
201320142015201620172013–2017

1Number of men planned for the screening99531166493278808963849390
2Actual number of men screened98881166693228821963749334
3Plan implementation, %99.35100.0299.95100.1599.9999.84
4Number of patients detected with prostate disease1962793552042141248
5Actual prostate disease detection rate, %1.982.393.822.312.222.53
6Planned prostate disease detection rate, %1.972.393.812.322.222.53
7The number of prostate cancer cases identified due to a pilot screening program1330173139130
8I Stage6310212
9II Stage524132835105
10III Stage2323212
11IV Stage001001
12The proportion of prostate cancer cases identified within the framework of pilot screening program0.10.30.20.350.400.26
13The proportion of early PCa cases identified within the framework of pilot screening program84.6290.0082.3590.3294.8790
14The proportion of late PCa cases identified within the framework of pilot screening program15.3810.0017.659.685.1310
15The number of newly diagnosed prostate cancer cases (including those identified due to the pilot screening program)9599101148125568
16I stage5873528
17II stage55596510799385
18III stage21202031698
19IV stage1412971557
20The proportion of prostate cancer cases identified at an early stage63.1667.6871.2974.3283.2072.71
21The proportion of prostate cancer cases identified at a late stage36.8432.3228.7125.6816.8027.29
22The proportion of newly diagnosed prostate cancer cases identified by the pilot screening program out of the total number of newly diagnosed cases of prostate cancer13.6830.3016.8320.9531.2022.89
23Total number of newly diagnosed cancers of all types2,1522,2722,2482,3732,44811,493
24The proportion of prostate cancer cases out of all cancer cases4.414.364.496.245.114.94

Prostate disease is any prostate disorder that results in elevated PSA levels.